Crestchem Limited

BSE: CRSTCHM

BSE

136.90 3.05 (2.28%)

Prev Close

133.85

Open Price

136

Volume

1,176

Today Low / High

134.1 / 137

52 WK Low / High

114 / 329

Range

130 - 144

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 136.9, reflecting a change of 3.05 (2.27867%). The expected target range on the BSE is 130 - 144. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

03 Oct 136.00 0.62%

01 Oct 133.00 0.64%

30 Sep 129.25 1.74%

29 Sep 139.70 -5.51%

26 Sep 132.50 1.28%

25 Sep 139.05 -0.90%

24 Sep 140.95 -1.42%

23 Sep 136.50 1.72%

22 Sep 127.95 6.37%

19 Sep 140.00 -5.61%

18 Sep 143.00 -0.70%

17 Sep 143.95 -2.71%

16 Sep 134.45 -0.74%

15 Sep 132.95 -1.13%

12 Sep 130.00 2.08%

11 Sep 128.65 2.49%

10 Sep 126.15 6.86%

09 Sep 123.95 2.22%

08 Sep 117.80 5.05%

05 Sep 127.20 -6.45%

Crestchem Limited Graph

If you are looking for the target price for Crestchem Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 136.90, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario	Price	Target	Range
Bullish Scenario	136.90	138.27	124.44 - 152.10
		139.64	111.71 - 167.57
		141.01	98.70 - 183.31
Bearish Scenario	136.90	135.53	121.98 - 149.08
		134.16	107.33 - 160.99
		132.79	92.96 - 172.63

ISIN

INE293N01016

Industry

Medical - Pharmaceuticals

Vol.Avg

2,411

Market Cap

410,700,000

Last Dividend

Official Website

Visit Website

IPO Date

1998-12-30

DCF Diff

-263.42

DCF

448

Financial Ratios Every Investor Needs

Stock Dividend of CRSTCHM

Date	Label	Adj Dividend	Dividend	Record Date	Payment Date	Declaration Date
2025-08-13	August 13, 25	1	1	2025-08-13	2025-09-20
2024-08-23	August 23, 24	0.5	0.5	2024-08-23	2024-09-29

Stock Rating Details for CRSTCHM

Metric	Value	Recommendation
Overall Rating	C+	Sell
DCF Score	5	Strong Buy
ROE Score	1	Strong Sell
ROA Score	1	Strong Sell
Debt-to-Equity (DE) Score	1	Strong Sell
Price-to-Earnings (PE) Score	3	Neutral
Price-to-Book (PB) Score	1	Strong Sell

Annual Financial Income Report

Date	Revenue	Co.Rev	GP	GPR	R&D Expenses	G&A Expenses	Operating Income	Net Income	EPS	EBITDA	NIR
2025-03-31	25.08 Cr	19.98 Cr	5.10 Cr	0.2033	0.00 Cr	0.24 Cr	3.23 Cr	2.73 Cr	9.08	3.72 Cr	0.1087
2024-03-31	21.18 Cr	16.10 Cr	5.08 Cr	0.2398	0.11 Cr	0.20 Cr	2.73 Cr	2.15 Cr	7.15	3.03 Cr	0.1013
2023-03-31	16.73 Cr	14.44 Cr	2.29 Cr	0.1367	0.00 Cr	0.13 Cr	0.81 Cr	0.69 Cr	2.31	0.97 Cr	0.0415
2022-03-31	7.95 Cr	6.13 Cr	1.82 Cr	0.2287	0.00 Cr	0.16 Cr	0.72 Cr	0.57 Cr	1.89	0.82 Cr	0.0714
2021-03-31	7.51 Cr	5.82 Cr	1.69 Cr	0.2249	0.00 Cr	0.08 Cr	0.64 Cr	0.57 Cr	1.91	0.71 Cr	0.0765

Annual Financials Balance Sheet

Date	C&C Equ.	Tot. Assets	Tot. Liab.	Stock. Equity	Tot. Debt	Net Debt	Inv.	PP&E (Net)	Curr. Def. Rev.	LT Invest.	Curr. Liab.
2025-03-31	0.73 Cr	10.54 Cr	3.07 Cr	7.4760 Cr	0.00 Cr	-0.73 Cr	0.00 Cr	0.26 Cr	0.00 Cr	5.88 Cr	2.9974 Cr
2024-03-31	0.15 Cr	7.14 Cr	2.24 Cr	4.7495 Cr	0.00 Cr	-0.15 Cr	0.00 Cr	0.17 Cr	0.00 Cr	4.60 Cr	2.2093 Cr
2023-03-31	0.87 Cr	4.79 Cr	2.03 Cr	2.7532 Cr	0.00 Cr	-0.87 Cr	-0.04 Cr	0.11 Cr	0.00 Cr	3.39 Cr	2.0212 Cr
2022-03-31	0.01 Cr	3.29 Cr	1.23 Cr	2.0597 Cr	0.27 Cr	0.26 Cr	0.00 Cr	0.19 Cr	0.21 Cr	1.93 Cr	1.2274 Cr
2021-03-31	0.03 Cr	3.00 Cr	1.51 Cr	1.4925 Cr	0.63 Cr	0.59 Cr	0.00 Cr	0.21 Cr	0.19 Cr	0.09 Cr	1.4561 Cr

Annual Financials Cash Flow Statement

Date	Operating Cash	Investing Cash	Financing Cash	Free Cash	Cash Change	Cash at End	CapEx	Income	Debt Repay	Dividends	Inventory
2025-03-31	2.0870 Cr	-1.4257 Cr	-0.0747 Cr	1.9465 Cr	0.5865 Cr	0.7315 Cr	-0.1405 Cr	2.7265 Cr	0.0000 Cr	-0.0747 Cr	-0.0003 Cr
2024-03-31	0.3479 Cr	-1.0657 Cr	-0.0062 Cr	0.4790 Cr	-0.7241 Cr	0.1450 Cr	-0.1151 Cr	2.1463 Cr	0.0000 Cr	0.0000 Cr	0.0000 Cr
2023-03-31	2.2106 Cr	-1.3414 Cr	-0.0098 Cr	2.1946 Cr	0.8594 Cr	0.8691 Cr	-0.0160 Cr	0.9382 Cr	-0.2670 Cr	0.0000 Cr	0.0025 Cr
2022-03-31	0.8188 Cr	-0.8279 Cr	-0.0158 Cr	0.8184 Cr	-0.0248 Cr	0.0097 Cr	-0.0004 Cr	0.7812 Cr	-0.3603 Cr	0.0000 Cr	0.0006 Cr
2021-03-31	0.3935 Cr	-0.3911 Cr	-0.0161 Cr	-0.0151 Cr	-0.0136 Cr	0.0345 Cr	-0.4086 Cr	0.6733 Cr	0.6121 Cr	0.0000 Cr	0.0032 Cr

Quarterly Financial Income Report

Date	Revenue	Co.Rev	GP	GPR	Operating Income	Net Income	EPS	EBITDA	NIR
2025-06-30	5.03 Cr	3.96 Cr	1.07 Cr	0.2136	0.34 Cr	0.35 Cr	1.16	0.49 Cr	0.0692
2025-03-31	7.37 Cr	5.77 Cr	1.61 Cr	0.2177	1.23 Cr	0.61 Cr	2.03	0.74 Cr	0.0828
2024-12-31	4.80 Cr	3.60 Cr	1.19 Cr	0.2490	0.64 Cr	0.52 Cr	1.74	0.74 Cr	0.1087
2024-09-30	7.80 Cr	5.58 Cr	2.22 Cr	0.2843	1.95 Cr	1.00 Cr	3.32	1.28 Cr	0.1278
2024-06-30	5.25 Cr	4.06 Cr	1.18 Cr	0.2257	0.75 Cr	0.60 Cr	1.99	0.84 Cr	0.1140

Quarterly Financials Balance Sheet

Date	Cash & Equiv.	Cash & Short-Term	Net Receivables	Total Curr. Assets	PP&E (Net)	Total Assets	Total Liabilities
2025-06-30	0.00 Cr	0.73 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	-7.48 Cr
2025-03-31	0.73 Cr	0.73 Cr	2.56 Cr	4.31 Cr	0.26 Cr	10.54 Cr	3.07 Cr
2024-12-31	0.00 Cr	0.14 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	-6.34 Cr
2024-09-30	0.14 Cr	0.14 Cr	1.54 Cr	2.15 Cr	0.17 Cr	8.07 Cr	1.73 Cr
2024-06-30	0.00 Cr	0.15 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	-4.90 Cr

Quarterly Financials Cash Flow Statement

Date	Net Income	Operating Cash Flow	Investing Cash Flow	Financing Cash Flow	Net Cash Change	Cash at End	Cash at Beginning	CapEx	Free Cash Flow
2025-06-30	0.35 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2025-03-31	0.61 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2024-12-31	0.52 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2024-09-30	1.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2024-06-30	0.60 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr

Splits History

Date	Label	Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name	Symbol	Price	Market Cap	Volume
MedPlus Health Services Limited	MEDPLUS	₹740.05	₹88,616,322,965.00	₹57,195.00

Key Executives

Manager of Finance & Accounts

Mr. Satish D. Panchal

Gender: male

Year Born:

Manager of Administration

Ms. Parul Dipak Patel

Gender: female

Year Born:

Chairman & MD

Mr. Dipak Narendraprasad Patel B.Sc., M.B.A.

Gender: male

Year Born: 1955

Chief Financial Officer, Company Secretary & Compliance Officer

Ms. Khyati Dipakkumar Vyas

Gender: female

Year Born:

FAQs about Crestchem Limited

Who is the CEO of the company?

The CEO is Dipak Narendraprasad Patel.

What is the current market price of the stock?

The current price is ₹136.90.

What is the 52-week price range?

The range is ₹114-329.

What is the market capitalization of the company?

The market capitalization is ₹41.07 crores.

What is the dividend yield?

The dividend yield is 0.73%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 16.58.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Crestchem Limited (ISIN: INE293N01016) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹41.07 crores and an average daily volume of 2,411 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹1.

Crestchem Limited

Crestchem Limited Graph

Crestchem Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

Overview of Crestchem Limited

Financial Ratios Every Investor Needs

Stock Dividend of CRSTCHM

Stock Rating Details for CRSTCHM

Annual Financial Income Report

Annual Financials Balance Sheet

Annual Financials Cash Flow Statement

Quarterly Financial Income Report

Quarterly Financials Balance Sheet

Quarterly Financials Cash Flow Statement

Splits History

Similar Stocks: Medical - Pharmaceuticals

Key Executives

FAQs about Crestchem Limited